Landscape of Cyclin Pathway Genomic Alterations Across 5,356 Prostate Cancers: Implications for Targeted Therapeutics

The cyclin pathway may confer resistance to standard treatments but also offer novel therapeutic opportunities in prostate cancer. Herein, we analyzed prostate cancer samples (majority metastatic) using comprehensive genomic profiling performed by next‐generation sequencing (315 genes, >500× cove...

Descripción completa

Detalles Bibliográficos
Autores principales: Jardim, Denis L., Millis, Sherri Z., Ross, Jeffrey S., Woo, Michelle Sue‐Ann, Ali, Siraj M., Kurzrock, Razelle
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Inc. 2021
Materias:
Brief Communications
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8018295/
https://www.ncbi.nlm.nih.gov/pubmed/33522043
http://dx.doi.org/10.1002/onco.13694

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8018295/
https://www.ncbi.nlm.nih.gov/pubmed/33522043
http://dx.doi.org/10.1002/onco.13694

Ejemplares similares